Merck Revenues Increase by 2.7% to E1.9 Billion
Published: 26-Oct-2009
For nine month period company recorded a revenues of E5.7 billion
Merck KGaA has announced that group total revenues rose 2.7% in the third quarter to E1,944m from E1,893m in the year-ago quarter. The group’s operating result declined by 28% to E222m in the third quarter. The group return on sales declined to 11.4% in the third quarter compared to 16.3% in the year-ago quarter.
The company's earnings before interest and tax (EBIT) fell by 28% to E222m in the third quarter compared to E309m in the year-ago quarter. Profit before tax fell 31% to E90m in the third quarter compared to E275m in the year-ago quarter.
For the nine month period, the group recorded a total revenues of E5,699.8m, compared to E5,654.1m for 2008, an increase of 0.8%. The group recorded a decline in the operating results to E604.8m from E989.4 in 2008, a decrease of 38.9%.
EBIT for the group also decreased to E536.0m from E989.4m in 2008, a decease of 45.8%. There was a decrease of 51.5% in profit after tax to E318.2m from E656.7m.
Karl-Ludwig Kley, chairman of Merck, said: “The third-quarter figures are showing improvement compared to the first half of 2009. Even in our chemical businesses, which were substantially impacted by the economic crisis, we see a clear trend toward recovery. We now can say with confidence that Merck will deliver what it promised earlier in the year.”
Network Sites

Suppliers To This Sector
Browse A-Z
World Courier
Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...
WebWise Learning
Turning Information into Working Knowledge ...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Valsynthese
Hazardous Chemistry in Safe Hands ...
USB
Products from Affymetrix ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
Enabling Drug Delivery Deal Making
Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...
Automating Training Control Processes to Comply with FDA Requirements
Well-managed training programs minimize the risk of non-compliance and improve product qua ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully